Indeed, in transgenic mice expressing human SOD1 with ALS-causing mutations (G37R and G93A), oral administration of a copper complex CuII (atsm) facilitates the copper binding of mutant SOD1 in their spinal cords and improves the neurological phenotype and survival [18–20]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.